OOU
5 FDA 510(k) clearances · Product code
85 daysmedian time to decision
221 days90th percentile
5clearances measured
FDA profile
- Official device name
- Parainfluenza Multiplex Nucleic Acid Assay
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.3980
- Medical specialty
- Microbiology
- FDA definition
- A parainfluenza multiplex nucleic acid assay is a multiplex in vitro diagnostic test for the simultaneous qualitative detection and discrimination of parainfluenza 1 virus, parainfluenza 2 virus, parainfluenza 3 virus and parainfluenza 4 virus nucleic acids isolated and purified from human respiratory specimens obtained from individuals exhibiting signs and symptoms of respiratory tract infections or viral culture. The detection and discrimination of human parainfluenza nucleic acids from symptomatic patients aid in the diagnosis of human respiratory tract parainfluenza infections if used in conjunction with other clinical and laboratory findings.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| Panther Fusion Paraflu Assay (K172282) | Hologic, Inc. | 2017-10-23 |
| ProParaFlu+ Assay (K153223) | Hologic, Inc. | 2015-12-09 |
| LYRA PARAINFLUENZA VIRUS ASSAY (K141927) | Quidel Corporation | 2014-10-09 |
| PROPARAFLU+ ASSAY (K132238) | Gen-Probe Prodesse, Inc. | 2013-08-26 |
| PROPARAFLU+ASSAY (K091053) | Prodesse, Inc. | 2009-11-20 |
Track OOU automatically
Every clearance here is in the API, with alerts when new ones post.